Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros


Marc Benioff, founder, chairman and CEO of enterprise cloud computing company Salesforce.

Kim Kulish | Corbis News | Getty Images

The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the latest regulatory filings from influential Wall Street pros. These big-name investors also made moves in nine other Club stocks during a strong three-month stretch that ended the best first half for the market in years.



Source

Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Health

Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. For […]

Read More
Hinge Health stock pops 6% after first quarterly report since IPO
Health

Hinge Health stock pops 6% after first quarterly report since IPO

Hinge Health co-founders, Gabriel Mecklenburg and Daniel Perez celebrate its initial public offering at the New York Stock Exchange on May 22, 2025. NYSE Shares of Hinge Health popped 6% in extended trading on Tuesday after the digital physical therapy company reported quarterly results for the first time since its debut on the New York […]

Read More
Trump says pharma tariffs could eventually reach up to 250%
Health

Trump says pharma tariffs could eventually reach up to 250%

U.S. President Donald Trump talks to members of the press at Lehigh Valley International Airport in Allentown, Pennsylvania, U.S., August 3, 2025. Ken Cedeno | Reuters President Donald Trump told CNBC’s “Squawk Box” on Tuesday that planned tariffs on pharmaceuticals imported into the U.S. could eventually reach up to 250%, the highest rate he has […]

Read More